Reach Us +443308085114
Editor - Sudhakar Akul Yakkanti | Center for Cancer & Metabolis | 2136
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Sudhakar Akul Yakkanti

Sudhakar Akul Yakkanti
Sudhakar Akul Yakkanti
Associate Director
Center for Cancer & Metabolism
Cell Signaling Laboratory
Bioscience Division
Stanford Research Institute (SRI) International
Tel. 402-498-6681
Fax: 402-498-6331


Sudhakar Akulapalli is the Director of Cell Signaling and Tumor Angiogenesis Laboratory Boys Town National Research Hospital Omaha, NE, USA. He is a Clinical Professor at Creighton University and Nebraska Medical Center. He did his postdoctoral training at Harvard Medical School Boston USA in 2003. He received PhD in 2001, MPhill in 1997, MSc in 1995, degrees in life sciences from University of Hyderabad; and BSc in Biology from SK University in 1993 from India. He has received President’s fellowship, GATE and CSIR fellowships from Government of India. He received Mahindra Mahindra Travel Award and YCS Award from FAMRI, he received BioBio Young Scientist Award from OMICS and RO1 grant award from NIH/NCI. He is serving as AIBS/NIHGrant reviewer and has published more than 30 research articles including Science JCI Cancer Cell PNAS Blood etc. He is serving as an Executive Editor and editorial board member of reputed journals and serving as a reviewer of 20 scientific journals.

Research Interest

Extracellular matrix and Integrin; Signaling Biology and significance of type IV collagen derived angioinhibitors;  Endogenous angioinhibitors role in Cancer and tumor microenvironment;  Hypoxic tumorangiogenesis; Mechanism of endothelial apoptosis;  Bioequivalence & Bioavailability of endogenous circulating angioinhibitors.